← Leaderboards
Katherine Wagner
Boston Biomedical Research Institute
$550,765
Attributed
$550,765
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $198.1K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$550,765 · 1
By mechanism
U54$550,765 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Biomedical Research Institute
Same institution · by research overlap
- Zenon Grabarek$5,030,679
- Victor A Raso$5,768,937
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsAcuteAdultDouble-Blind MethodBaseBinding (Molecular Function)AnimalsBiologicalDimerDoseBiopsyBiopsy SpecimenBloodChronicClinical DataClinical TreatmentClinical Trial Protocol DocumentClinical TrialsAwardCollaborationsCommunitiesDesignDetectionEfficacy Trial
Grant awards (5)
Clinical Trials and Biomarkers of Myostatin Inhibition$198,090
U54 · FY2012 · HD · contact PI
Clinical Trials and Biomarkers of Myostatin Inhibition$90,155
U54 · FY2011 · HD · contact PI
Clinical Trials and Biomarkers of Myostatin Inhibition$84,029
U54 · FY2010 · HD · contact PI
Clinical Trials and Biomarkers of Myostatin Inhibition$88,076
U54 · FY2009 · HD · contact PI
Clinical Trials and Biomarkers of Myostatin Inhibition$90,415
U54 · FY2008 · HD · contact PI